Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisa Bello

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Trends in Cancer|March 12, 2022
Elevated circulating memory T cells precede immunotherapy toxicities in melanomaElisa Bello, Michael Dougan
Acta Haematologica|October 3, 2023
Clinico-Radio-Pathologic Correlation of Leukostasis in Acute Myeloid Leukemia with FLT3 MutationElisa Bello, Haihui Liao, Shyam A Patel
Journal for Immunotherapy of Cancer|February 13, 2019
Antitumor response to microscopic melanoma in the gastric mucosa mimicking ipilimumab-induced gastritisElisa Bello, Justine V Cohen, Mari Mino-Kenudson, et al.
Leukemia Research|September 20, 2023
Harnessing autologous immune effector mechanisms in acute myeloid leukemia: 2023 update of trials and tribulationsShyam A Patel, Elisa Bello, Andrew Wilks, et al.
Science Advances|November 24, 2023
DGKα/ζ inhibition lowers the TCR affinity threshold and potentiates antitumor immunityRakeeb Kureshi, Elisa Bello, Courtney T S Kureshi, et al.
Scientific Reports|September 18, 2024
Targeted proteomics of cerebrospinal fluid in treatment naïve multiple sclerosis patients identifies immune biomarkers of clinical phenotypesAlexandra Rabin, Elisa Bello, Saurabh Kumar, et al.
Nanoscale|December 19, 2023
AGuIX nanoparticle-nanobody bioconjugates to target immune checkpoint receptorsLéna Carmès, Guillaume Bort, François Lux, et al.
Gastroenterology|June 1, 2023
Transforming Growth Factor-β Blockade in Pancreatic Cancer Enhances Sensitivity to Combination ChemotherapyLi Qiang, Megan T Hoffman, Lestat R Ali, et al.
Nature Biotechnology|November 1, 2022
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapyAlfredo Quijano-Rubio, Aladdin M Bhuiyan, Huilin Yang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2023
cIAP1/2 Antagonism Induces Antigen-Specific T Cell-Dependent ImmunityKatherine S Ventre, Kevin Roehle, Elisa Bello, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Trends in Cancer|March 12, 2022
Elevated circulating memory T cells precede immunotherapy toxicities in melanomaElisa Bello, Michael Dougan
Acta Haematologica|October 3, 2023
Clinico-Radio-Pathologic Correlation of Leukostasis in Acute Myeloid Leukemia with FLT3 MutationElisa Bello, Haihui Liao, Shyam A Patel
Journal for Immunotherapy of Cancer|February 13, 2019
Antitumor response to microscopic melanoma in the gastric mucosa mimicking ipilimumab-induced gastritisElisa Bello, Justine V Cohen, Mari Mino-Kenudson, et al.
Leukemia Research|September 20, 2023
Harnessing autologous immune effector mechanisms in acute myeloid leukemia: 2023 update of trials and tribulationsShyam A Patel, Elisa Bello, Andrew Wilks, et al.
Science Advances|November 24, 2023
DGKα/ζ inhibition lowers the TCR affinity threshold and potentiates antitumor immunityRakeeb Kureshi, Elisa Bello, Courtney T S Kureshi, et al.
Scientific Reports|September 18, 2024
Targeted proteomics of cerebrospinal fluid in treatment naïve multiple sclerosis patients identifies immune biomarkers of clinical phenotypesAlexandra Rabin, Elisa Bello, Saurabh Kumar, et al.
Nanoscale|December 19, 2023
AGuIX nanoparticle-nanobody bioconjugates to target immune checkpoint receptorsLéna Carmès, Guillaume Bort, François Lux, et al.
Gastroenterology|June 1, 2023
Transforming Growth Factor-β Blockade in Pancreatic Cancer Enhances Sensitivity to Combination ChemotherapyLi Qiang, Megan T Hoffman, Lestat R Ali, et al.
Nature Biotechnology|November 1, 2022
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapyAlfredo Quijano-Rubio, Aladdin M Bhuiyan, Huilin Yang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2023
cIAP1/2 Antagonism Induces Antigen-Specific T Cell-Dependent ImmunityKatherine S Ventre, Kevin Roehle, Elisa Bello, et al.
Pageof 1